Danaher | DHR - Assets


Danaher reported $93.28B in Assets for its fiscal quarter ending in September of 2026.





Assets Change Date
Abbott USD 110.43B 23.72B Mar/2026
Agilent USD 13.97B 902M Jun/2026
Align Technology USD 6.52B 103.03M Sep/2026
Becton, Dickinson and Co. USD 50.73B 101M Jun/2026
Bio Techne USD 2.59B 36.12M Jun/2026
Bio-Rad Laboratories USD 10.25B 462M Jun/2026
Boston Scientific USD 45.22B 865M Jun/2026
Bruker USD 6.05B 77.8M Jun/2026
Charles River Laboratories USD 7.53B 198.16M Jun/2026
Danaher USD 93.28B 914M Sep/2026
Dentsply International USD 5.2B 25M Jun/2026
Edwards Lifesciences USD 13.87B 545.9M Jun/2026
ESCO Technologies USD 2.42B 14.2M Jun/2026
Fortive USD 11.5B 112.2M Sep/2026
Henry Schein USD 11.38B 77M Jun/2026
Illumina USD 6.65B 91M Jun/2026
Intuitive Surgical USD 19.35B 1.53B Sep/2026
IQVIA Holdings USD 30.47B 593M Sep/2026
Keysight Technologies USD 11.92B 183M Jun/2026
Laboratory Of America USD 18.92B 392.3M Sep/2026
Medtronic USD 93.31B 278M Jun/2026
Mettler Toledo International USD 3.67B 2.03M Jun/2026
Myriad Genetics USD 638.9M 34.8M Jun/2026
OraSure Technologies USD 360.55M 18.62M Jun/2026
Quest Diagnostics USD 17.22B 282M Sep/2026
Quidel USD 5.72B 86.6M Jun/2026
Repligen USD 2.93B 23.77M Sep/2026
Revvity USD 12.05B 49.24M Jun/2026
Roper Industries USD 34.34B 831.2M Sep/2026
Stryker USD 47.25B 683M Sep/2026
Thermo Fisher Scientific USD 114.23B 1.06B Sep/2026
Waters USD 24.75B 220M Jun/2026
Zimmer Biomet Holdings USD 22.8B 76.2M Jun/2026